Latest debt-to-equity ratio

Madrigal Pharmaceuticals Debt-to-equity ratio

Direct answer

Madrigal Pharmaceuticals's debt-to-equity ratio is 66.4%.

The verified market snapshot reports 66.4%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 30, 2026.

Get free Madrigal Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
66.4%